发明名称 NALTREXONE LONG ACTING FORMULATIONS AND METHODS OF USE
摘要 The invention described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes describes long acting formulations of naltrexone, which achieve serum AUC values at least twice that of oral administration.
申请公布号 EP1740120(A2) 申请公布日期 2007.01.10
申请号 EP20050728952 申请日期 2005.03.18
申请人 ALKERMES CONTROLLED THERAPEUTIC, II 发明人 EHRICH, ELLIOT
分类号 A61F2/00;A01N25/00;A61K9/00;A61K9/14;A61K9/50;A61K31/44;A61K31/485 主分类号 A61F2/00
代理机构 代理人
主权项
地址